BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2003) 76, 916-919
© 2003 British Institute of Radiology
doi: 10.1259/bjr/77297900

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahn, K J
Right arrow Articles by Kim, C C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahn, K J
Right arrow Articles by Kim, C C

Case report

Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity

K J Ahn, MD1, J W Lee, MD1, S T Hahn, MD1, D W Yang, MD2, P S Kim, MD2, H J Kim, MD3 and C C Kim, MD3

Departments of 1 Diagnostic Radiology, 2 Neurology and 3 Haematology, The Catholic University of Korea, Seoul, Korea

Correspondence: Dr S T Hahn, Department of Radiology, St Mary's Hospital, #62 Youido-Dong, Yongdeungpo-Gu, Seoul 150–713, Korea


    Abstract
 Top
 Abstract
 Introduction
 Case report
 Discussion
 References
 
FK506 is a newly developed potent immunosuppressant for preventing rejection after organ transplantation. However, FK506 can induce central nervous system toxicity. Until now the pathogenic mechanism of FK506 neurotoxicity was unclear. We report the findings of diffusion-weighted MRI and apparent diffusion coefficient (ADC) mapping of a FK506 neurotoxicity patient who showed increased signal intensities in both parieto-occipital lobes on T2 weighted images, diffusion-weighted images and ADC maps. These findings suggest that a vasogenic oedema rather than a cytotoxic oedema may play a pivotal role in FK506 neurotoxicity pathogenesis.


    Introduction
 Top
 Abstract
 Introduction
 Case report
 Discussion
 References
 
The MR findings of FK506 (tacrolimus) neurotoxicity are well documented: high signal intensities on T2 weighted images involving the parieto-occipital lobes bilaterally [13]. However, the exact pathophysiological mechanism remains unclear.

Both diffusion-weighted MRI and apparent diffusion coefficient (ADC) mapping make it possible to differentiate between a vasogenic oedema and a cytotoxic oedema [46]. We report a FK506 neurotoxicity patient in whom diffusion-weighted MRI and ADC mapping were used to differentiate the cause of the high signal intensity observed in T2 weighted images.


    Case report
 Top
 Abstract
 Introduction
 Case report
 Discussion
 References
 
A 22-year-old man with severe aplastic anaemia underwent bone marrow transplantation. Cyclophosphamide and total body irradiation were used as conditioning. The patient had never received either intrathecal chemotherapy or brain irradiation prior to this conditioning. 2 days prior to his allogenic transplantation, FK506 was first given as a prophylaxis for graft-versus-host disease (3.3 mg day-1), and was maintained for 20 post-operative days. 21 days after the transplantation, the patient was started on an oral preparation of FK506 (7–10 mg day-1). On post-operative day 37, the patient presented with a drowsy mental status, upper extremity rigidity and a rolling eyeball movement of both eyes. The FK506 trough level was 17.2 mg ml-1. Both the serum chemistries and haematologies were not thought to be cause of these symptoms. The patient's blood pressure was 140/80 mm Hg.

On the next day after onset of patient's manifestations, brain MRI (1.5 T Magnetom Vision Plus; Siemens, Erlangen, Germany) was performed. On T2 weighted images (repetition time (TR)/echo time (TE)=4000/99, slice thickness 6 mm, number of slices 19, field of view 230 x 230 mm, matrix size 198 x 512) multiple cortical and subcortical high signal intensities were revealed in both parieto-occipital lobes and both frontal watershed zones (Figure 1aGo). These results strongly suggested posterior reversible leukoencephalopathy syndrome. On diffusion-weighted images (single-shot spin-echo echo-planar pulse sequence with b-value=1000 s mm-2, superior–inferior direction of diffusion encoding gradient, TR/TE=4000/110, field of view 230 x 230 mm, matrix size 128 x 128, number of slices 17, slice thickness 5 mm, and number of excitation 1) isosignal or high signal intensities were shown on the areas of increased signal intensities indicated by the T2 weighted images (Figure 1bGo). ADC mapping (3 different b-values: 0 s mm-2, 500 s mm-2, 1000 s mm-2, and 3 orthogonally directed diffusion encoding gradients for each b-value) was performed to elucidate the cause of the increased signal intensity on the diffusion-weighted images. On the ADC maps, the areas corresponding to the increased signal intensities on diffusion-weighted images showed increased signal intensity, even in the frontal watershed zones, when compared with the adjacent brain parenchymal signal intensity (Figure 1cGo). The areas of increased signal intensity on ADC maps appeared to be larger compared with those on the diffusion-weighted images. From both the clinical and radiological findings, FK506 neurotoxicity was strongly suspected, and thus FK506 was discontinued. The patient's condition greatly improved over the next few days after cessation of FK506 and he was discharged after 4 weeks.



View larger version (101K):
[in this window]
[in a new window]
 
Figure 1. 22-year-old man who underwent bone marrow transplantation for severe aplastic anaemia. (a) T2 weighted MRI at the level of basal ganglia and splenic portion of corpus callosum shows bilateral high signal intensities involving cortical and subcortical white matter in both occipital lobes (arrows). At left basal ganglia, haemorrhagic dark signal intensity with surrounding oedema is demonstrated. (b) Diffusion-weighted image with superior–inferior direction of diffusion encoding gradient at the same level of (a) demonstrates also increased signal intensities (arrows). (c) ADC mapping obtained through the same level of (b) demonstrates increased signal intensity in right occipital lobe, representing vasogenic oedema (arrow). There is no area of decreased signal intensity in both occipital lobes.

 

    Discussion
 Top
 Abstract
 Introduction
 Case report
 Discussion
 References
 
The macrolide antibiotic FK506 has immunosuppressant activity similar to cyclosporine. However, it is between 10 and 100 times more potent than cyclosporine in terms of its immunosuppressive properties [7]. Widespread use of FK506 as an immunosuppressive agent following organ transplantation has led to a number of neurological syndromes. The most common symptoms and signs of FK506 neurotoxicity are altered mental status (ranging from drowsiness to stupor), seizures, headaches and visual abnormalities [1, 2]. The onset may be acute or subacute, and seizures may be focal or generalized [2]. In solid organ transplant recipients, these major neurological toxicities have been observed in approximately 5% of patients receiving FK506 and have occurred a median of 10–13 days after its initial administration [8].

These neurological symptoms and signs in association with the signal abnormalities on the T2 weighted MRI involving the posterior white matter have been described as a complication of cyclosporine therapy [1, 2, 9]. The neuroimaging findings in FK506-induced neurotoxicity are similar to those reported with cyclosporine-induced toxicity. Both cause abnormalities predominantly affecting the parieto-occipital lobes, although other regions of the brain may also be affected. These symptoms generally resolve over time [10]. Both cyclosporine and FK506 neurotoxicity can be included in reversible posterior leukoencephalopathy [11].

Schwartz et al [12] suggested that the neurotoxic effects of cyclosporine appear to be identical to those with hypertensive encephalopathy, which may be induced by a breakdown of autoregulation preferentially affecting the posterior circulation. According to their study, hypertension plays a pivotal role in the pathogenesis of cyclosporine neurotoxicity.

Vasculopathy also has been suggested as a main pathogenic mechanism. Lesion locations in the brain anastomotic border zones and the high co-existence of neurological symptoms with bone marrow-associated thrombotic microangiopathy indicate an underlying cerebral vasculopathy [13]. Diffuse vessel injury can lead to regional cerebral hypoperfusion, with the most severe flow reduction expected in the anastomotic border zones. Although mechanism for vasculopathy was different, Truwit et al [9] also suggested that endothelin, a potent vasoconstrictor, may play an important role in the pathogenesis of cyclosporine neurotoxicity by vasospam.

Ultimately, the pathophysiology of both cyclosporine and FK506 neurotoxicity remain unclear. Two pathogenic mechanisms have been suggested. One is that a cerebral vasospasm results in ischaemia and consequent cytotoxic oedema. This is supported by angiographic findings of a diffuse or focal vasospasm and by infarctions in posterior leukoencephalopathy patients. Pathological findings of widespread arteriolar vasospasm and thrombosis and multifocal infarctions also support this theory [14]. An alternative theory is that acute hypertension in posterior leukoencephalopathy induces a loss of autoregulation with passive dilatation of the cerebral arterioles; the hydrostatic pressure results in the extravasation of proteins and fluid into the interstitium [15, 16]. Multiple reports of reversible T2 hyperintense white matter lesions with predominance in the posterior circulation as well as increased perfusion with SPECT scanning in patients with posterior leukoencephalopathy support this latter theory.

Diffusion-weighted imaging provides a means of identifying a cytotoxic oedema caused by acute ischaemia or infarction through a reduction in the diffusibility of protons [4, 5]. This elicits a bright signal on the heavily diffusion-weighted images, and is believed to reflect increased intracellular and decreased extracellular fluid resulting from sodium pump failure.

However, on diffusion weighted images a vasogenic oedema can also be visualized as increased signal intensity-T2 shine through effect [17]. Consequently, ADC mapping is necessary to differentiate a cytotoxic oedema from a vasogenic oedema.

Our patient's findings of increased signal intensity on both diffusion-weighted images and ADC mapping indicate that not cytotoxic oedema but vasogenic oedema was the main cause of increased signal intensities on T2 weighted images. A vasogenic oedema can develop in the course of cerebral ischaemia and also secondary to increased interstitial fluid by breakdown of autoregulation.

In our case the MRI was taken just 1 day after patient's manifestations. In acute ischaemic stroke diffusion coefficients are initially decreased, and usually normalized similar to those of normal brain tissue 1 week after onset of symptoms [18]. Thus it may not be academic to regard this vasogenic oedema as a manifestation of vasculopathy induced ischaemia. Our patient's findings are consistent with the hypothesis that FK506 neurotoxicity results from a breakdown of autoregulation.

In conclusion, we have reported the findings of diffusion-weighted MRI and ADC mapping in a FK506 neurotoxicity patient who showed increased signal intensities in both parieto-occipital lobes on T2 weighted images. On ADC mapping, there was no area with decreased signal intensity. Otherwise, the areas showing increased signal intensity on T2 weighted images were demonstrated with increased signal intensity on ADC mapping. These findings suggest that a vasogenic oedema was the main cause of high signal intensities on T2 weighted images, and breakdown of autoregulation rather than vasculopathy induced ischaemia played a pivotal role in FK506 neurotoxicity pathogenesis.

Received for publication August 30, 2002. Revision received February 4, 2003. Accepted for publication March 25, 2003.


    References
 Top
 Abstract
 Introduction
 Case report
 Discussion
 References
 

  1. Appignani BA, Bhadelia RA, Blacklow SC, Wang AK, Roland SF, Freeman RB Jr. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol 1996;166:683–8.[Abstract/Free Full Text]
  2. Torocsik HV, Curless RG, Post J, Tzakis AG, Pearse L. FK506-induced leukoencephalopathy in children with organ transplants. Neurology 1999;52:1497–500.[Abstract/Free Full Text]
  3. Steg RE, Kessinger A, Wszolek ZK. Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation. Bone Marrow Transplant 1999;23:959–62.[CrossRef][Medline]
  4. Chien D, Kwong KK, Gress DR, Buonanno FS, Buxton RB, Rosen BR. MR diffusion imaging of cerebral infarction in humans. AJNR Am J Neuroradiol 1992;13:1097–102.[Abstract]
  5. Sevick RJ, Kanda F, Mintorovitch J, Arieff AI, Kucharczyk J, Tsuruda JS, et al. Cytotoxic brain edema: assessment with diffusion weighted MR imaging. Radiology 1992;185:687–90.[Abstract/Free Full Text]
  6. Tien RD, Felsberg GJ, Friedman H, Brown M, MacFall J. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 1994;162:671–7.[Abstract/Free Full Text]
  7. Keenan RJ, Konishi H, Kawai A, Paradis IL, Nunley DR, Iacono AT, et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 1995;60:580–5.[Abstract/Free Full Text]
  8. Eidelman BH, Abu-Elmagd K, Wilson J, Fung JJ, Alessiani M, Jain A, et al. Neurologic complications of FK 506. Transplant Proc 1991;23:3175–8.[Medline]
  9. Truwit CL, Denaro CP, Lake JR, Demarco T. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651–9.[Abstract]
  10. Freise CE, Rowley H, Lake J, Hebert M, Ascher NL, Roberts JP. Similar clinical presentation of neurotoxicity following FK506 and cyclosporin in a liver transplant recipient. Transplant Proc 1991;23:3173–4.[Medline]
  11. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;22:494–500.
  12. Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, Robson CD, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627–31.[Abstract/Free Full Text]
  13. Bartynski WS, Grabb BC, Zeigler Z, Lin L, Andrews DF. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr 1997;21:872–80.[CrossRef][Medline]
  14. Govan A. The pathogenesis of eclamptic lesions. J Pathol Microbiol 1961;24:561–75.
  15. Auer L. The sausage-string phenomenon in acutely induced hypertension: arguments against the vasospasm theory in the pathogenesis of acute hypertensive encephalopathy. Eur Neurol 1978;17:166–73.[Medline]
  16. Standgaard S, Paulson O. Cerebral autoregulation. Stroke 1984;15:413–6.[Free Full Text]
  17. Gray L, MacFall. Overview of diffusion imaging. In: Castillo M, editor. Magnetic resonance imaging clinics of north America: new techniques in MR neuroimaging. Philadelphia, PA: W.B. Saunders, 1998:128–35.
  18. Lansberg MG, Thijs VN, O'Brien MW, Ali JO, Crespigny AJ, Tong DC, et al. Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke. AJNR Am J Neuroradiol 2001;22:637–44.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
NeurologyHome page
C. M. Lavigne, D. A. Shrier, M. Ketkar, and J. M. Powers
Tacrolimus leukoencephalopathy: A neuropathologic confirmation
Neurology, September 28, 2004; 63(6): 1132 - 1133.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahn, K J
Right arrow Articles by Kim, C C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahn, K J
Right arrow Articles by Kim, C C


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS